Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$5.8 - $8.98 $1.2 Million - $1.85 Million
206,093 New
206,093 $1.34 Million
Q3 2022

Nov 14, 2022

BUY
$7.55 - $11.25 $355,567 - $529,818
47,095 Added 30.88%
199,601 $1.68 Million
Q2 2022

Aug 15, 2022

SELL
$6.8 - $14.23 $106,413 - $222,685
-15,649 Reduced 9.31%
152,506 $1.16 Million
Q1 2022

May 11, 2022

SELL
$13.42 - $23.38 $79,862 - $139,134
-5,951 Reduced 3.42%
168,155 $2.33 Million
Q4 2021

Feb 11, 2022

SELL
$12.78 - $23.74 $90,904 - $168,862
-7,113 Reduced 3.93%
174,106 $4.13 Million
Q3 2021

Nov 12, 2021

BUY
$11.73 - $16.08 $113,217 - $155,204
9,652 Added 5.63%
181,219 $2.39 Million
Q2 2021

Aug 11, 2021

BUY
$12.85 - $16.2 $219,555 - $276,793
17,086 Added 11.06%
171,567 $0
Q1 2021

May 13, 2021

BUY
$13.84 - $17.8 $109,889 - $141,332
7,940 Added 5.42%
154,481 $0
Q4 2020

Feb 09, 2021

SELL
$12.4 - $17.6 $34,013 - $48,276
-2,743 Reduced 1.84%
146,541 $0
Q3 2020

Nov 12, 2020

SELL
$11.59 - $14.93 $99,453 - $128,114
-8,581 Reduced 5.44%
149,284 $0
Q2 2020

Aug 12, 2020

BUY
$11.79 - $15.97 $1.16 Million - $1.57 Million
98,496 Added 165.9%
157,865 $0
Q1 2020

May 06, 2020

BUY
$9.31 - $21.24 $4,059 - $9,260
436 Added 0.74%
59,369 $0
Q4 2019

Feb 14, 2020

BUY
$13.91 - $21.48 $52,774 - $81,495
3,794 Added 6.88%
58,933 $0
Q3 2019

Nov 07, 2019

BUY
$15.84 - $30.01 $184,536 - $349,616
11,650 Added 26.79%
55,139 $0
Q2 2019

Aug 12, 2019

BUY
$17.38 - $26.88 $274,916 - $425,187
15,818 Added 57.16%
43,489 $1.17 Million
Q1 2019

May 14, 2019

BUY
$9.2 - $21.21 $254,573 - $586,901
27,671 New
27,671 $477,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.